Scarica l'app Stockscreener
1.40
1.41%
-0.02
Dopo l'orario di chiusura:
1.40
Iridex Corp Borsa (IRIX) Ultime notizie
Iridex to Report Third Quarter 2024 Financial Results on November 12, 2024 - StockTitan
IRIX Stock Sees Significant Drop Amid Market Fluctuation - GuruFocus.com
IRIDEX (NASDAQ:IRIX) Earns Hold Rating from Analysts at StockNews.com - Defense World
IRIDEX Co. (NASDAQ:IRIX) Short Interest Up 9.9% in October - Defense World
Ophthalmic Photocoagulator Market to Witness Huge Growth by 2032 |Alcon, NIDEK, IRIDEX, Lumenis Be - openPR
IRIDEX (NASDAQ:IRIX) Research Coverage Started at StockNews.com - Defense World
Ophthalmology Devices Market projected to grow by USD 19.1 Billion from 2024-2028, driven by AI-powered innovations and rising prevalence of ophthalmic diseasesTechnavio - The Malaysian Reserve
IRIDEX Corp (IRIX) Q2 2024 Earnings Call Highlights: Navigating Growth and Challenges - Yahoo Finance
IRIX stock touches 52-week low at $1.62 amid market challenges By Investing.com - Investing.com South Africa
IRIX stock touches 52-week low at $1.62 amid market challenges - Investing.com Australia
Iridex names Patrick Mercer as new CEO to drive strategic review - Investing.com
Iridex Appoints Patrick Mercer as Chief Executive Officer - StockTitan
Medical Laser Market Size, Share, Growth and Industry Trends – news - North America Agile Program ...
Medical Laser Technology Market Size, Share, Trends & Forecast - Third Eye News
IRIDEX (NASDAQ:IRIX) Now Covered by StockNews.com - Defense World
Medical Lasers Market 2024: Exploring Industry Demand, Technological Advancements, And Future Prospects - WhaTech
Global Diabetes Associated Ophthalmic Treatment Market Size To Exceed USD 56.43 Billion By 2033 l CAGR Of 6.61% - India Shorts
Iridex (NASDAQ:IRIX) Stock Quotes, Forecast and News Summary - Benzinga
Iridex Frustrates, But Expect A Transaction By Year-End (NASDAQ:IRIX) - Seeking Alpha
Iridex finds accounting error, Q1 loss to widen by 1 cent/shr - Reuters
IRIDEX Corporation (NASDAQ:IRIX) Q2 2024 Earnings Call Transcript - Insider Monkey
StockNews.com Initiates Coverage on IRIDEX (NASDAQ:IRIX) - Defense World
Earnings call: IRIDEX sees growth in Q2 with strategic review underway - Investing.com Canada
Iridex revenue drops to USD 12.6M in Q2 2024 - Medical Buyer
IRIDEX Corporation (IRIX) Q2 2024 Earnings Call Transcript - Seeking Alpha
Iridex: Q2 Earnings Snapshot - Houston Chronicle
Iridex Reports Second Quarter 2024 Financial Results - Yahoo Finance
Iridex announces convertible note financing - Medical Buyer
Iridex secures $3.5 million in private placement financing - Investing.com
IRIDEX (NASDAQ:IRIX) Now Covered by Analysts at StockNews.com - Defense World
Iridex Announces Convertible Note Financing - Yahoo Finance
IRIDEX (IRIX) Set to Announce Earnings on Thursday - Defense World
Energy-Based Aesthetic Devices Market size is set to grow by USD 2.13 billion from 2024-2028, Increasing demand for aesthetic procedures boost the market, Technavio - The Malaysian Reserve
Iridex to Report Second Quarter 2024 Financial Results on August 8, 2024 - StockTitan
IRIDEX (NASDAQ:IRIX) Coverage Initiated at StockNews.com - Defense World
ENT Laser Devices Market to Witness an Outstanding Growth by 2032 - openPR
IRIDEX Co. (NASDAQ:IRIX) Short Interest Update - Defense World
Energy-Based Aesthetic Devices Market size is set to grow by USD 2.13 billion from 2024-2028, Increasing demand for aesthetic procedures to boost the market growth, Technavio - The Malaysian Reserve
Energy-Based Aesthetic Devices Market Size Is Set To Grow By USD 2.13 Billion From 2024-2028, Increasing Demand For Aesthetic Procedures To Boost The ... - MENAFN.COM
Retinal Laser Photocoagulation Market Size Report, 2030 - Grand View Research
Head-To-Head Survey: QT Imaging (NASDAQ:QTI) versus IRIDEX (NASDAQ:IRIX) - American Banking and Market News
ENT Laser Devices Market size is set to grow by USD 130 million from 2024-2028, Increasing prevalence of ent disorders boost the market, Technavio - The Malaysian Reserve
Medical Laser Technologies Global Market Research Report - GlobeNewswire
IRIDEX Co. (NASDAQ:IRIX) Short Interest Up 8.7% in June - Defense World
IRIDEX (NASDAQ:IRIX) Receives New Coverage from Analysts at StockNews.com - Defense World
Tempest Therapeutics executive purchases $9,951 in company stock By Investing.com - Investing.com India
Kintara Therapeutics restructures share designations By Investing.com - Investing.com
Zoom's chief accounting officer sells over $280,000 in company stock By Investing.com - Investing.com
PubMatic CEO Rajeev Goel sells shares worth over $1 million By Investing.com - Investing.com UK
Hagerty completes warrant exchange offer - Investing.com
IRIDEX moves to transfer stock listing to Nasdaq Capital Market - Investing.com
Iridex to Present at the Lytham Partners Fall 2021 Investor Conference - Quantisnow
Iridex Announces Second Quarter 2021 Financial Results - Quantisnow
Iridex to Present at the 2021 Stifel Virtual Healthcare Conference - Quantisnow
Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2022 - Quantisnow
Iridex to Participate in Fireside Chat with Stifel Equity Research - Quantisnow
IRIDEX moves to transfer stock listing to Nasdaq Capital Market By Investing.com - Investing.com
0.47%
1.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):